Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-047820

Chief Financial Officer sold 1,496 shares at $12.09 ($18,087)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2020-08-18 Sale −1,496 $12.09 $18,087 133,530 D
Open-market sales · 1,496 sh · avg $12.09 · $18,087
Loading xslF345X03/doc4.xml…